Market Access Monitor Year 2016 in Review

Overall, 471 news were reported, with about 30% coming from England (140 reports). Other countries with frequent updates of reimbursement system included Belgium (45 reports), Germany (37 reports), Russia (35 reports) and France (31 reports).

Broad range of topics were reported for England, from developments of National Tariff to announcements about new commissioning decisions by NHS England. In Belgium, the most of the decisions were related to the changes in reimbursement Nomenclature by INAMI/RIZIV. Germany came very much into focus with new legislation about evidence assessment for the first-time high-class risk applicants to NUB. Russia demonstrated stably high level of activities, mainly due to new legislation, issued by Ministry of Health.

Reporting activity per month is presented below. The pick in the first half of the year was in March, and from July there was a stable increase in number of reports ending up with 72 news in December. Increase in number of reports relates to update of our methodology and inclusion criteria to capture all relevant information for our customers. 

Finally, 75% of news did not refer to specific technology and reflected general change in the system. Among remaining reports, 14% were focused on cardiovascular technologies (17 reports), 10% - on radiology and radiotherapy (12 reports), 8% - on in-vitro diagnostics (10 reports) and orthopedics (9 reports). Remaining 60% was distributed between 25 other technological areas. Distribution of the reports across technological areas for 80% of the reports is shown below.